Dr Rocco Friebel

This course is compulsory on the Executive MSc in Evaluation of Health Care Interventions and Outcomes, in collaboration with NICE. This course is not available as an outside option.

Health care systems are complex organisational structures governed by an ambition to provide high-quality health care services to its population. In this context, governance describes a framework through which individual stakeholders are being held accountable to improving the quality of services and safe-guarding high standards of care. The framework also ensures a consistent evaluation and regulation of care processes and is crucial for the efficient functioning of health care systems around the world.

This course provides a detailed perspective on the complexities surrounding the interplay between different stakeholders in the regulation of health care markets and the problems facing the management of health care services. The course builds on theoretical concepts and on principles of sound economic analysis and exposes students to learning from regulatory experiences beyond the health sector, including from data sciences.

Following completion of this course, students will have an advanced understanding of the theoretical underpinnings of regulation and governance and they will be familiar with key topics of current concern, including the problems associated with health care management, planning, purchasing and commissioning, and quality of care. Knowledge drawn from this course will equip students with the necessary skills required to understand the complexities of health care regulation and governance and to critically assess policy decisions in their respective health systems.

The course will be delivered in no less than 21 hours and includes lectures and seminars.

Formative coursework will be completed in class. Students will be provided with a case study of a regulatory policy, which ought to be analysed and critiqued. Feedback will be provided, allowing students to develop skills to complete the summative assignment successfully.

• A. Dixon, T. Harrison and C. Mundle, Economic regulation in health care: What can we learn from other regulators? King’s Fund, London, 2011, available at: https://www.kingsfund.org.uk/sites/default/files/Economic-regulation-in-health-care-paper-The-Kings-Fund-November-2011_0.pdf

• R. Busse, N. Klazinga, D. Panteli and W. Quentin, Improving healthcare quality in Europe: Characteristics, effectiveness and implementation of different strategies World Health Organisation, Geneva, 2019, available at: https://apps.who.int/iris/bitstream/handle/10665/327356/9789289051750-eng.pdf?sequence=1&isAllowed=y

• R. Field, Health Care Regulation in America: Complexity, Confrontation, and Compromise, Oxford University Press, 2006, pp. 336.

• M. Gaynor, C. Propper and S. Seiler, “Free to choose? Reform choice and consideration sets in the English National Health Service”, American Economic Review, vol 106 (11), 2016, pp. 3521-57.

• M. Lodge and L. Stirton Accountability in the regulatory state. In: Baldwin, Robert, Cave, Martin and Lodge, Martin, (eds.) The Oxford Handbook of Regulation. Oxford handbooks in business and management. Oxford University Press, 2010.

• R. Saltman, R. Busse, E. Mossialos (eds) Regulating entrepreneurial behaviour in European health care systems, Open University Press, 2002.

• R. Saltman and A. Duran “Governance, Government, and the Search for New Provider Models”, Int J Health Policy Manag, 2015, 4(1), pp. 1-10.

• M. Lodge (2014) Regulatory capture recaptured. Public Administration Review, 74 (4). pp. 539-542.

• J. Costa-Font, G. Turati and A. Batinti The Political Economy of Health and Healthcare – Rise of the Patient Citizen, 2020, available at https://www.cambridge.org/core/books/political-economy-of-health-and-healthcare/8AFCCB199BE731939F2A5A285A0BFF59

• E. Mossialos, G. Permanand, R. Baeten and T. Hervey. Health Systems Governance in Europe: The Role of European Union Law and Policy. Cambridge University Press, 2010.

• G. Permanand and E. Mossialos “Constitutional asymmetry and pharmaceutical policy-making in the European Union” Journal of European Public Policy. 2005;12(4): 687-709

Essay (100%, 6000 words) post-summer term.